180 Life Sciences Corp. Files 2024 10-K Amendment
Ticker: FRMM · Form: 10-K/A · Filed: Apr 25, 2025 · CIK: 1690080
| Field | Detail |
|---|---|
| Company | 180 Life Sciences CORP. (FRMM) |
| Form Type | 10-K/A |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, pharmaceuticals
TL;DR
180 Life Sciences filed its 2024 10-K amendment. Check financials.
AI Summary
180 Life Sciences Corp. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, formerly known as KBL Merger Corp. IV, is incorporated in Delaware and operates in the Pharmaceutical Preparations sector. This filing was made on April 25, 2025.
Why It Matters
This amendment provides updated financial and operational information for 180 Life Sciences Corp. for the fiscal year 2024, which is crucial for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This filing is an amendment to a routine annual report and does not appear to contain significant new negative information.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the annual report.)
- 001-38105 — SEC File Number (Identifies the company's filings with the SEC.)
Key Players & Entities
- 180 Life Sciences Corp. (company) — Registrant
- KBL Merger Corp. IV (company) — Former company name
- December 31, 2024 (date) — Fiscal year end
- April 25, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific changes or additions are detailed in this Amendment No. 1 to the 10-K filing?
The filing is an amendment to the Form 10-K for the fiscal year ended December 31, 2024, indicating that the original filing may have contained errors or omissions that are now being corrected or supplemented.
What is the primary business of 180 Life Sciences Corp.?
180 Life Sciences Corp. operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code [2834].
When was 180 Life Sciences Corp. formerly known as?
The company was formerly known as KBL Merger Corp. IV, with a date of name change on November 15, 2016.
Where is 180 Life Sciences Corp. headquartered?
The company's principal executive offices are located at 3000 El Camino Real, Bldg. 4, Suite 200, Palo Alto, CA 94306.
What is the significance of the filing date of April 25, 2025?
The filing date of April 25, 2025, indicates when this amendment to the annual report was submitted to the SEC.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 25, 2025 regarding 180 Life Sciences Corp. (FRMM).